Status:
COMPLETED
Resting Heart Rate in Chronic Obstructive Pulmonary Disease
Lead Sponsor:
Izmir Katip Celebi University
Conditions:
Pulmonary Rehabilitation
Exercise
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
110 COPD patients who were participated in the PR program were included in the study. Resting Heart Rate , pulmonary functions, functional capacity, perception of dyspnea, quality of life and psycholo...
Detailed Description
In many studies, it has been reported that baroreceptor activity and heart rate variability decrease and resting heart rate (RHR) increases in COPD patients due to changes in cardiac autonomic functio...
Eligibility Criteria
Inclusion
- Patients diagnosed with COPD according to GOLD and completed the 2-day / 8-week PR program
Exclusion
- With cardiovascular disease
- With additional diseases such as diabetes
- Receiving medical treatment that affects the autonomic nervous system
- Patients receiving long-term oxygen therapy
Key Trial Info
Start Date :
January 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2021
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT04890080
Start Date
January 1 2017
End Date
April 1 2021
Last Update
May 18 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.